172 related articles for article (PubMed ID: 25582722)
1. [Some thoughts on the links between LC-MS/MS and therapeutic drug monitoring].
Saint-Marcoux F
Ann Biol Clin (Paris); 2015; 73(1):49-53. PubMed ID: 25582722
[TBL] [Abstract][Full Text] [Related]
2. Advances in antifungal drug measurement by liquid chromatography-mass spectrometry.
Zheng YZ; Wang S
Clin Chim Acta; 2019 Apr; 491():132-145. PubMed ID: 30685359
[TBL] [Abstract][Full Text] [Related]
3. Mass Spectrometry in Clinical Laboratory: Applications in Therapeutic Drug Monitoring and Toxicology.
Garg U; Zhang YV
Methods Mol Biol; 2016; 1383():1-10. PubMed ID: 26660168
[TBL] [Abstract][Full Text] [Related]
4. LC-MS/MS for immunosuppressant therapeutic drug monitoring.
Sallustio BC
Bioanalysis; 2010 Jun; 2(6):1141-53. PubMed ID: 21083213
[TBL] [Abstract][Full Text] [Related]
5. The current role of liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressant and antiretroviral drugs.
Taylor PJ; Tai CH; Franklin ME; Pillans PI
Clin Biochem; 2011 Jan; 44(1):14-20. PubMed ID: 20599871
[TBL] [Abstract][Full Text] [Related]
6. Liquid chromatography-tandem mass spectrometry method as the golden standard for therapeutic drug monitoring in renal transplant.
Aucella F; Lauriola V; Vecchione G; Tiscia GL; Grandone E
J Pharm Biomed Anal; 2013 Dec; 86():123-6. PubMed ID: 23995754
[TBL] [Abstract][Full Text] [Related]
7. Recent development in application of high performance liquid chromatography-tandem mass spectrometry in therapeutic drug monitoring of immunosuppressants.
Yang Z; Wang S
J Immunol Methods; 2008 Jul; 336(2):98-103. PubMed ID: 18547583
[TBL] [Abstract][Full Text] [Related]
8. Multicenter evaluation of the thermo scientific prelude for measurement of immunosuppressant drugs using sample preparation liquid chromatography-tandem mass spectrometry.
Peake RW; Hartigan CR; Esposito CL; Kellogg MD; Gabler J; Wang S; Breaud A; Di Bussolo J; Moskowitz J; Clarke W
Ther Drug Monit; 2015 Apr; 37(2):161-71. PubMed ID: 25072947
[TBL] [Abstract][Full Text] [Related]
9. Experiences from using LC-MS/MS for analysis of immunosuppressive drugs in a TDM service.
Pohanka A; Rosenborg S; Lindh JD; Beck O
Clin Biochem; 2016 Sep; 49(13-14):1024-31. PubMed ID: 27372284
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic drug monitoring and LC-MS/MS.
Adaway JE; Keevil BG
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 883-884():33-49. PubMed ID: 21992751
[TBL] [Abstract][Full Text] [Related]
11. LC-MS/MS as a tool for TDM services: Where are we?
Shipkova M; Svinarov D
Clin Biochem; 2016 Sep; 49(13-14):1009-23. PubMed ID: 27163969
[No Abstract] [Full Text] [Related]
12. Experience with therapeutic drug monitoring of three antifungal agents using an LC-MS/MS method in routine clinical practice.
Yoon SJ; Lee K; Oh J; Woo HI; Lee SY
Clin Biochem; 2019 Aug; 70():14-17. PubMed ID: 31175859
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic drug monitoring by LC-MS-MS with special focus on anti-infective drugs.
Müller DM; Rentsch KM
Anal Bioanal Chem; 2010 Nov; 398(6):2573-94. PubMed ID: 20652551
[TBL] [Abstract][Full Text] [Related]
14. Clinical applications of MS-based protein quantification.
Sabbagh B; Mindt S; Neumaier M; Findeisen P
Proteomics Clin Appl; 2016 Apr; 10(4):323-45. PubMed ID: 27061318
[TBL] [Abstract][Full Text] [Related]
15. Alternative matrices for therapeutic drug monitoring of immunosuppressive agents using LC-MS/MS.
Ghareeb M; Akhlaghi F
Bioanalysis; 2015; 7(8):1037-58. PubMed ID: 25966013
[TBL] [Abstract][Full Text] [Related]
16. Recent advances in analytical methods for the therapeutic drug monitoring of immunosuppressive drugs.
Zhang Y; Zhang R
Drug Test Anal; 2018 Jan; 10(1):81-94. PubMed ID: 28851030
[TBL] [Abstract][Full Text] [Related]
17. Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS.
Alffenaar JW; Wessels AM; van Hateren K; Greijdanus B; Kosterink JG; Uges DR
J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jan; 878(1):39-44. PubMed ID: 19945360
[TBL] [Abstract][Full Text] [Related]
18. Impact of glucuronide interferences on therapeutic drug monitoring of posaconazole by tandem mass spectrometry.
Krüger R; Vogeser M; Burghardt S; Vogelsberger R; Lackner KJ
Clin Chem Lab Med; 2010 Dec; 48(12):1723-31. PubMed ID: 20704538
[TBL] [Abstract][Full Text] [Related]
19. Comparison of everolimus QMS immunoassay on Architect ci4100 and liquid chromatography/mass spectrometry: lack of agreement in organ-transplanted patients.
Hoffer E; Kurnik D; Efrati E; Scherb I; Karasik M; Ring G; Bentur Y
Ther Drug Monit; 2015 Apr; 37(2):214-9. PubMed ID: 25162218
[TBL] [Abstract][Full Text] [Related]
20. Analytical performance of a new liquid chromatography/tandem mass spectrometric method for determination of everolimus concentrations in whole blood.
McMillin GA; Johnson-Davis K; Dasgupta A
Ther Drug Monit; 2012 Apr; 34(2):222-6. PubMed ID: 22322402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
